1,582
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Challenges to optimising uptake and delivery of a HPV vaccination programme for men who have sex with men

ORCID Icon &
Pages 1541-1543 | Received 29 Nov 2018, Accepted 13 Dec 2018, Published online: 30 Jan 2019

References

  • Parkin DM. Cancers attributable to infection in the UK in 2010. Brit J Cancer. 2011;105:S49–56. doi:10.1038/bjc.2011.484.
  • Grulich AE, Poynten IM, Machalek DA, Jin FY, Templeton DJ, Hillman RJ. The epidemiology of anal cancer. Sex Health. 2012;9:504–508. doi:10.1071/SH12070.
  • Public Health England. HIV in the United Kingdom: 2014 report; 2014 [accessed 2018 Nov 28] https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/401662/2014_PHE_HIV_annual_report_draft_Final_07-01-2015.pdf.
  • Office for National Statistics. Sexual identity, UK: 2015; 2016 [accessed 2018 Nov 28] https://www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/sexuality/bulletins/sexualidentityuk/2015.
  • Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. JNCI. 2000;92:1500–1510.
  • Deeken JF, Tjen ALA, Rudek MA, Okuliar C, Young M, Little RF, Dezube BJ. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012;55:1228–1235. doi:10.1093/cid/cis613.
  • Bower M, Collins S, Cottrill C, Cwynarski K, Montoto S, Nelson M, Nwokolo N, Powles T, Stebbing J, Wales N, et al. British HIV Association guidelines for HIV-associated malignancies 2008. HIV Med. 2008;9:336–388. doi:10.1111/j.1468-1293.2008.00608.x.
  • World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017. Geneva, Switzerland: World Health Organization; 2017.
  • Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis. 2011;11:39–44. doi:10.1016/S1473-3099(10)70225-5.
  • Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect. 2009;85:499–502. doi:10.1136/sti.2009.037788.
  • Public Health England. HPV vaccination pilot for men who have sex with men (MSM); 2016 [accessed 2018 Nov 28] https://www.gov.uk/government/publications/hpv-vaccination-pilot-for-men-who-have-sex-with-men-msm.
  • Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD. Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect. 2014;90:515–523. doi:10.1136/sextrans-2013-051357.
  • Gerend MA, Madkins K, Phillips G, Mustanski B. Predictors of human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis. 2016;43:185–191. doi:10.1097/Olq.0000000000000408.
  • Reiter PL, McRee AL, Katz ML, Paskett ED. Human papillomavirus vaccination among young adult gay and bisexual men in the United States. Am J Pub Health. 2015;105:96–102. doi:10.2105/Ajph.2014.302095.
  • Rank C, Gilbert M, Ogilvie G, Jayaraman GC, Marchand R, Trussler T, Hogg RS, Gustafson R, Wong T, Team MS. Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs. Vaccine. 2012;30:5755–5760. doi:10.1016/j.vaccine.2012.07.001.
  • Nadarzynski T, Smith H, Richardson D, Bremner S, Llewellyn C. Men who have sex with men who do not access sexual health clinics nor disclose sexual orientation are unlikely to receive the HPV vaccine in the UK. Vaccine. 2018;36:5065–5070. doi:10.1016/j.vaccine.2018.06.075.
  • Wheldon CW, Daley EM, Buhi ER, Baldwin JA, Nyitray AG, Giuliano AR. HPV vaccine decision-making among young men who have sex with men. Health Educ J. 2017;76:52–65. doi:10.1177/0017896916647988.
  • Brooks H, Llewellyn CD, Nadarzynski T, Pelloso FC, De Souza Guilherme F, Pollard A, Jones CJ. Sexual orientation disclosure in health care: a systematic review. Brit J Gen Pract. 2018;68:e187–e196. doi:10.3399/bjgp18X694841.
  • World Health Organisation. Report of the SAGE working group on vaccine hesitancy; 2014 [accessed 2018 Nov 28] www.who.int/immunization/sage/meetings/2014/october/SAGE_working_group_revised_report_vaccine_hesitancy.pdf?ua=1.
  • Nadarzynski T, Smith H, Richardson D, Pollard A, Llewellyn C. Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: A qualitative analysis. Brit J Health Psychol. 2017. doi:10.1111/bjhp.12233.
  • Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Publ Int. 2017;18:149–207. doi:10.1177/1529100618760521.
  • Herrero R, González P, Markowitz LE. Present status of human papillomavirus vaccine development and implementation. Lancet Oncol. 2015;16:e206–e216. doi:10.1016/S1470-2045(14)70481-4.
  • Arbyn M, Xu L, Simoens C, Martin‐Hirsch PPL. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018. doi:10.1002/14651858.CD009069.pub3.
  • Castellsague X, Paavonen J, Jaisamrarn U, Wheeler CM, Skinner SR, Lehtinen M, Naud P, Chow SN, Del Rosario-Raymundo MR, Teixeira JC, et al. Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial. BMC Infect Dis. 2014;14:551. doi:10.1186/s12879-014-0551-y.